Conversations powered by KPMG Luxembourg

Web3, or wait and see?

30 min · 16 jun 2025
aflevering Web3, or wait and see? artwork

Beschrijving

In our third episode on digital assets and blockchain, we explore the evolution of Web3: from a speculative concept to a maturing global industry, with a focus on Luxembourg’s emerging role in the space. Our guest, - Maxime Baron, CEO of Hash Consulting - discusses how blockchain technology, once compared to the "floppy disk era", is steadily becoming more user-friendly and mainstream. We break down what Web3 really means, the importance of decentralization, and how regulation can either foster or stifle innovation depending on its execution. From media misconceptions and meme coins to serious infrastructure and financial applications, we examine how blockchain is maturing despite growing pains.

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de Conversations powered by KPMG Luxembourg community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

10 afleveringen

aflevering Where pharma and funds converge | Part 1 artwork

Where pharma and funds converge | Part 1

In Part 1 of this two-episode special of Conversations powered by KPMG Luxembourg, we dive into the converging worlds of the funds industry and pharmaceuticals. Featuring Annick Breton (Partner, Head of Consulting at KPMG Luxembourg), this episode brings together Romain Labbé (Secretary General at the IML), Natasha Deloge (Head of the Innovation Division at the CSSF), Pierre Mottion (Head of DLT and Strategy/Investment Fund Services at Clearstream), and Matthias Van den Eede (Head of Digital Business Development & Beewise at Azimut Investments), as they discuss the common similarities and challenges affecting their industries. Part 1 of this topic delves into the issues surrounding ongoing consumer confidence and how it is affecting the pharmaceutical and investment funds ecosystems.

28 feb 202526 min